Unlocking CNS insights: Continuous CSF sampling in first-in-human Alzheimer’s trials

This case study highlights how Fortrea enabled continuous cerebrospinal fluid (CSF) sampling in a first-in-human (FIH) Alzheimer’s study—an approach that allowed the sponsor to capture dynamic CNS biomarker movement and significantly enhance decision-making.

Connect with us

We’ve been driving innovation with our tailored clinical solutions for 30+ years. Let’s connect.

I am interested in

* denotes required fields

Upload RFP

(Word, PDF, PPT, Excel, Image)
One file only.
60 MB limit.
Allowed types: gif, jpg, jpeg, png, bmp, txt, rtf, html, pdf, doc, docx, ppt, pptx, xls, xlsx, xml.

First Name*

Last Name*

Job Title*

Company*

Business Email*

Business Phone

Country HQ*

State

Description*

I agree to receive other communications from Fortrea Inc

I agree to be contacted about products and services and receive other communications from Fortrea Inc. Please review Fortrea's Privacy Policy for further information. By submitting below, you consent to allow Fortrea Inc to store and process the personal information submitted above to provide you the content requested.

By clicking submit below, you consent to allow Fortrea Inc to store and process the personal information submitted above to provide you the content requested.

Explore Careers at Fortrea

Join our Site Network

Learn more about participating in a Fortrea Clinical Trial